panaxydol has been researched along with Cancer of Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, L; Mao, W; Song, L; Wang, Z; Yin, M; Zhao, W | 1 |
| Guo, LC; Song, L; Sun, YN; Wang, ZJ; Yin, M | 1 |
2 other study(ies) available for panaxydol and Cancer of Liver
| Article | Year |
|---|---|
Panaxydol inhibits the proliferation and induces the differentiation of human hepatocarcinoma cell line HepG2.
Topics: Alkaline Phosphatase; alpha-Fetoproteins; Base Sequence; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Diynes; DNA Primers; Down-Regulation; Fatty Alcohols; gamma-Glutamyltransferase; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Microscopy, Electron, Transmission; Reverse Transcriptase Polymerase Chain Reaction; Up-Regulation | 2009 |
Induction of differentiation by panaxydol in human hepatocarcinoma SMMC-7721 cells via cAMP and MAP kinase dependent mechanism.
Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Cell Differentiation; Cell Proliferation; Cell Survival; Cyclic AMP; Depression, Chemical; Diynes; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Extracellular Signal-Regulated MAP Kinases; Fatty Alcohols; Humans; Liver Neoplasms; Microscopy, Electron, Transmission; Signal Transduction; Tumor Cells, Cultured | 2011 |